Adenosine-mono-phosphate recalls
The FDA has published 1 recall involving Adenosine-mono-phosphate since 2013. The latest was reported on 17 Jul 2013. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2013
Last 12 months0reported
Class I00% of total
Ongoing1latest 17 Jul 2013
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why adenosine-mono-phosphate is recalled
Companies
By year
Ongoing adenosine-mono-phosphate recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Adenosine-Mono-Phosphate Injection, 200 mg/ml recalled | Lowlite Investments | Sterility | Nationwide |
All adenosine-mono-phosphate recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Adenosine-Mono-Phosphate Injection, 200 mg/ml recalled | Lowlite Investments | Sterility | Nationwide |
Should you stop taking Adenosine-mono-phosphate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.